in page functions

07 December 2013

PCV launch Afghanistan 1

Pneumococcal vaccine to protect more than a million children in Afghanistan from leading child killer

Pneumonia accounts for 25% of deaths of children under five in Afghanistan each year.

06 December 2013

Nelson Mandela and GAVI representatives

GAVI Alliance pays tribute to Nelson Mandela

Following the death of Nelson Mandela, Dagfinn Høybråten, Chair of the GAVI Alliance Board, and Dr Seth Berkley, CEO of the GAVI Alliance, issued statements

28 November 2013

Default library results

Guillaume Grosso appointed head resource mobilisation in European markets

Former director of ONE Campaign’s Paris office joins GAVI Alliance.

26 November 2013

WHO_Alejandro_Costa_Burkina Faso_Yellow fever-s.jpg

GAVI Alliance to support Nigeria's first new national yellow fever vaccination campaign in 30 years

Mass preventive campaign will protect close to 60 million children and adults.

07 November 2013

Germany statement

GAVI Alliance welcomes Germany’s continued commitment to immunisation

German support set to benefit East African Community and help improve supply chain.

05 November 2013


GAVI Alliance welcomes introduction of two life-saving vaccines in Senegal

Senegalese children to benefit from pneumococcal and measles-rubella vaccines .

24 October 2013

Aid Transparency Index 2013

GAVI Alliance a top performer in leading transparency index

Commitment to transparency and data quality recognised.

22 October 2013

UNICEF Cambodia

GAVI supports Cambodia’s campaign to vaccinate children against measles and rubella

More than four million children will receive the measles-rubella vaccine over the next three months.

09 October 2013

Default library results

Vaccine to protect South Asian children against devastating disease set for GAVI support

Chinese vaccine industry enters world stage with WHO prequalified Japanese encephalitis vaccine

09 October 2013

Default library results

GAVI welcomes Canada's support for measles vaccines

GAVI welcomes Canada’s US$ 20 million pledge to accelerate access to measles vaccines.


close icon

modal window here